Early detection of pancreatic cancer
- PMID: 32657789
- DOI: 10.1097/MOG.0000000000000663
Early detection of pancreatic cancer
Abstract
Purpose of review: Pancreatic cancer is the third leading cause of cancer death and with a dismal 5-year survival of 10%. Poor survival of pancreatic cancer is mostly due to its presentation and diagnosis at a late stage. The present article aims to update clinicians with recent progress in the field of early detection of pancreatic cancer.
Recent findings: Pancreatic cancer screening is not recommended in the general population due to its low prevalence. In this review, we discuss high-risk groups for pancreatic cancer, including inherited predisposition to pancreatic cancer, new-onset diabetes, mucinous pancreatic cyst, and chronic pancreatitis. We discuss methods of enrichment of high-risk groups with clinical models using electronic health records and biomarkers. We also discuss improvements in imaging modalities and emerging role of machine learning and artificial intelligence in the field of imaging and biomarker to aid in early identification of pancreatic cancer.
Summary: There are still vast challenges in the field of early detection of pancreatic cancer. We need to develop noninvasive prediagnostic validated biomarkers for longitudinal surveillance of high-risk individuals and imaging modalities that can identify pancreatic cancer early.
Similar articles
-
Early detection of pancreatic cancer.Lancet Gastroenterol Hepatol. 2020 Jul;5(7):698-710. doi: 10.1016/S2468-1253(19)30416-9. Epub 2020 Mar 2. Lancet Gastroenterol Hepatol. 2020. PMID: 32135127 Free PMC article. Review.
-
Prediagnostic Image Data, Artificial Intelligence, and Pancreatic Cancer: A Tell-Tale Sign to Early Detection.Pancreas. 2020 Aug;49(7):882-886. doi: 10.1097/MPA.0000000000001603. Pancreas. 2020. PMID: 32675784
-
Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.World J Gastroenterol. 2020 Apr 14;26(14):1660-1673. doi: 10.3748/wjg.v26.i14.1660. World J Gastroenterol. 2020. PMID: 32327914 Free PMC article.
-
Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery.Cancer Control. 2023 Jan-Dec;30:10732748231154711. doi: 10.1177/10732748231154711. Cancer Control. 2023. PMID: 36916724 Free PMC article. Review.
-
The role of biomarkers in the early detection of pancreatic cancer.Fam Cancer. 2024 Aug;23(3):309-322. doi: 10.1007/s10689-024-00381-4. Epub 2024 Apr 25. Fam Cancer. 2024. PMID: 38662265 Free PMC article. Review.
Cited by
-
Self-assembling dendrimer nanosystems for specific fluorine magnetic resonance imaging and effective theranostic treatment of tumors.Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2322403121. doi: 10.1073/pnas.2322403121. Epub 2024 Jun 12. Proc Natl Acad Sci U S A. 2024. PMID: 38865273
-
Screening of genes characteristic of pancreatic cancer by LASSO regression combined with support vector machine and recursive feature elimination, and immune correlation analysis.J Int Med Res. 2024 Mar;52(3):3000605241233160. doi: 10.1177/03000605241233160. J Int Med Res. 2024. PMID: 38456653 Free PMC article.
-
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC).Br J Cancer. 2023 Sep;129(5):782-790. doi: 10.1038/s41416-023-02344-5. Epub 2023 Jul 13. Br J Cancer. 2023. PMID: 37443348 Free PMC article.
-
Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach.Oncol Lett. 2023 May 19;26(1):285. doi: 10.3892/ol.2023.13871. eCollection 2023 Jul. Oncol Lett. 2023. PMID: 37274465 Free PMC article.
-
Mitochondrial Metabolism in Pancreatic Ductal Adenocarcinoma: From Mechanism-Based Perspectives to Therapy.Cancers (Basel). 2023 Feb 8;15(4):1070. doi: 10.3390/cancers15041070. Cancers (Basel). 2023. PMID: 36831413 Free PMC article. Review.
References
-
- Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014; 74:2913–2921.
-
- Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med 2014; 371:1039–1049.
-
- Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet 2016; 388:73–85.
-
- Pereira SP, Oldfield L, Ney A, et al. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol 2020; S2468-1253:30416–30419.
-
- Henrikson NB, Aiello Bowles EJ, Blasi PR, et al. Screening for pancreatic cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2019; 322:445–454.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
